Montag & Associates’s ARK Genomic Revolution ETF ARKG Stock Holding History

Montag & Associates’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-290	Closed	-$6.02K	–	952
2025 Q1	$6.02K	Hold	290	–	–	﹤0.01%	831
2024 Q4	$6.83K	Hold	290	–	–	﹤0.01%	814
2024 Q3	$7.42K	Hold	290	–	–	﹤0.01%	835
2024 Q2	$6.81K	Hold	290	–	–	﹤0.01%	804
2024 Q1	$8.34K	Hold	290	–	–	﹤0.01%	775
2023 Q4	$9.52K	Hold	290	–	–	﹤0.01%	778
2023 Q3	$8.08K	Hold	290	–	–	﹤0.01%	765
2023 Q2	$9.89K	Hold	290	–	–	﹤0.01%	758
2023 Q1	$8.72K	Hold	290	–	–	﹤0.01%	754
2022 Q4	$8.19K	Hold	290	–	–	﹤0.01%	754
2022 Q3	$10K	Hold	290	–	–	﹤0.01%	729
2022 Q2	$9K	Hold	290	–	–	﹤0.01%	697
2022 Q1	$13K	Hold	290	–	–	﹤0.01%	698
2021 Q4	$18K	Hold	290	–	–	﹤0.01%	685
2021 Q3	$22K	Hold	290	–	–	﹤0.01%	660
2021 Q2	$27K	Sell	290 -1	-0.3%	-$85	﹤0.01%	626
2021 Q1	$26K	Buy	291 +1	+0.3%	+$99	﹤0.01%	635
2020 Q4	$27K	Buy	+290	New	+$23.1K	﹤0.01%	606

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Montag & Associates's ARKG Position: Q2 2025 in Review

Montag & Associates sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2025, closing a stake of 290 shares — an estimated $6.02K sold.

Montag & Associates first reported a position in ARKG in Q4 2020 and held it in 18 quarters. The position peaked at $27K in Q2 2021. 213 funds tracked by Wall St. Rank hold ARKG as of Q2 2025.

Montag & Associates reported no remaining ARK Genomic Revolution ETF position as of Q2 2025 after selling out during the quarter.
Montag & Associates sold 290 ARK Genomic Revolution ETF shares in Q2 2025, an estimated $6.02K.
Montag & Associates first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 18 quarters.
Montag & Associates's ARK Genomic Revolution ETF position peaked at $27K in Q2 2021.
213 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2025.

Based on Montag & Associates's 13F filing for Q2 2025, filed 7 Aug 2025.